We are excited to share our latest edition of the Frier Levitt Life Sciences Newsletter, a thorough guide providing vital perspectives on the constantly
changing field of pharmacy law. We are committed to keeping you up to date on all the lates developments within the industry, and this edition is packed with essential updates on the most pressing topics.
In this edition, we cover a wide range of topics shaping the future of pharmacy law:
- Unveiling Medicare Advantage Abuses: Gain insight into the questionable practices within Medicare Advantage, specifically coding errors, and how they impact the pharmacy landscape.
- Florida’s Prescription Drug Reform Act’s Anti Patient Steering Provisions: Delve into the provisions of Florida’s Prescription Drug Reform Act, designed to protect patients from unethical steering practices, and how this benefits independent pharmacies.
- Navigating the World of Copay Coupons and PBM Audits: Discover the complexities of copay coupons and the increased scrutiny they face in PBM audits.
- Physician Access to “Unclaimed” Rebates through Rebate Aggregators: Take a deep dive into the growing trend of third-party companies helping physicians and facilities access “unclaimed” rebates from prescription drug manufacturers.
- Time for PBM Year-End Re-credentialing Requests and Performance Reviews: Stay updated on the crucial process of PBM year-end re-credentialing and performance reviews.
- PBMs to Likely Increase Audits as They Prepare to “Clean-Up” Provider Networks by End of Year: Explore the anticipated increase in PBM audits as they prepare to enhance provider networks by year-end.
- PBM Audit Guidelines that Pharmacies Need to Know: Understand the essential guidelines in PBM audits to avoid alleged non-compliance as a reason for significant clawbacks.
- Addressing Underpayment, Untimely Payment, and Outright Non-Payment Issues Faced by Home Infusion Pharmacies: Gain insights into the tactics employed by health insurance companies to avoid payment to home infusion providers and explore the legal tools available to pharmacies to address payment discrepancies.
- Uptick in Government Investigation and PBM Audits Over COVID-19 Test Kits: Explore the rise in government investigations and PBM audits related to COVID-19 test kits.
- Pharmaceutical Manufacturers Threatening Litigation Over Patient Savings Programs: Learn about the resurgence of an older trend, where pharmaceutical manufacturers are challenging pharmacies over patient savings programs.
- PBMs Targeting Auto-Refill Policies: Discover how PBMs are focusing on auto-refill policies and their potential impact.
- New York Proposes A Mandatory Prescription Dispensing Fee: Learn about the proactive steps that New York has taken to address the involvement of PBMs in the prescription drug marketplace, and the impact of this mandatory dispensing fee.
- Providers Billing to Medicare Advantage Should be Aware of a Recent Humana Lawsuit Against CMS: Stay informed about the recent Humana lawsuit against CMS and its implications for providers billing to Medicare Advantage.
In our Practice Spotlight section, we provide an overview of our services defending pharmacies in PBM audits. Learn how our attorneys can assist you through this onerous process.
Learn about upcoming Frier Levitt webinars and presentations -these programs are designed to keep you well-informed and equipped with the knowledge essential for success in the life sciences sector.
